Gf Fund Management Co. Ltd. Cullinan Oncology, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,491 shares of CGEM stock, worth $11,435. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,491
Previous 1,223
21.91%
Holding current value
$11,435
Previous $14.9 Million
24.23%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CGEM
# of Institutions
155Shares Held
68.6MCall Options Held
15.6KPut Options Held
17.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$58.7 Million10.72% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$44.1 Million1.91% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.86MShares$29.6 Million0.74% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$27.2 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$26.2 Million15.23% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $350M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...